최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Pediatric diabetes, v.2 no.1, 2001년, pp.2 - 11
Pietropaolo, Massimo , Becker, Dorothy J
초록이 없습니다.
Bach The NOD mouse Res Immunol 1997 148 285 10.1016/s0923-2494(97)87235-5
Atkinson The NOD mouse model of type 1 diabetes: as good as it gets? Nature Med 1999 10.1038/9442 5 601
Rossini Spontaneous diabetes in gnotobiotic BB/W rat Diabetes 1979 10.2337/diab.28.11.1031 28 1031
Like Spontaneous autoimmune diabetes mellitus in the BB rat Diabetes 1982 10.2337/diab.31.1.S7 31 Suppl. 1 7
Knip IDDM prevention trials in progress - a critical assessment J Pediatr Endocrinol Metab 1998 2 371
Sperling Aspects of the etiology, prediction, and prevention of insulin-dependent diabetes mellitus in childhood Pediatr Clin North Am 1997 10.1016/S0031-3955(05)70476-4 44 269
Naik Preservation of β cell function in type 1 diabetes Diabetes Rev 1999 7 154
Tercyak Patient and family reflections on the use of subcutaneous insulin to prevent diabetes: a retrospective evaluation from a pilot prevention trial J Diabetes Complications 1998 12 279 10.1016/s1056-8727(98)00005-1
Rabinovich Prevention of type 1 diabetes Med Clin North Am 1998 10.1016/S0025-7125(05)70022-5 82 739
The Diabetes Control and Complication Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. Diabetes Control Complications Trial J Pediatr 1994 125 188
Becker Intensive diabetes therapy in childhood: is it achievable? Is it desirable? Is it safe? J Pediatr 1999 10.1016/S0022-3476(99)70194-0 134 392
Rosenbloom Therapeutic controversy. Prevention and Treatment of Diabetes in Children J Clin Endocrinol Metab 2000 85 494
Akerblom Emergence of diabetes associated autoantibodies in the nutritional prevention of IDDM (TRIGR) project Diabetes 2000 48 Suppl.1 A45
Eisenbarth Type I diabetes mellitus: a chronic autoimmune disease N Engl J Med 1986 10.1056/NEJM198605223142106 314 1360
Theofilopoulos The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition Immunol Today 1995 10.1016/0167-5699(95)80095-6 16 90
Bellgrau Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. 1999 1
Rose Handbook of Immunology. 1997 111
Pietropaolo Molecular Biology of Diabetes. 1994 1
Galperin Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases Int Arch Allergy Immunol 1996 10.1159/000237390 111 337
Grubin A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM Diabetologia 1994 10.1007/BF00408469 37 344
Gianani ICA512 autoantibody radioassay Diabetes 1995 10.2337/diab.44.11.1340 44 1340
Beever Highly sensitive assays of autoantibodies to thyroglobulin and thyroid peroxidase Clin Chem 1989 10.1093/clinchem/35.9.1949 35 1949
Bingley Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6 Br Med J 1989 10.1136/bmj.298.6673.558 298 558
Ziegler Immunotherapy of Type I Diabetes. 1989 155
Kostraba Incidence of insulin-dependent diabetes mellitus in Colorado Epidemiology 1992 10.1097/00001648-199205000-00008 3 232
LaPorte Clinico-Genetic Genesis of Diabetes Mellitus. International Congress Series 597. 1982 66
Barmeier Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies Diabetologia 1991 10.1007/BF00401518 34 727
Riley A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes N Engl J Med 1990 10.1056/NEJM199010253231704 323 1167
Maclaren Perspectives in diabetes. How, when, and why to predict IDDM Diabetes 1988 10.2337/diab.37.12.1591 37 1591
Bingley Perspectives in diabetes. Can we really predict IDDM? Diabetes 1993 10.2337/diab.42.2.213 42 213
Maclaren Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (Type 1) diabetes in relatives J Autoimmun 1999 12 279 10.1006/jaut.1999.0281
Dorman Diabetes in America. 1995 165
Laporte RE Matsushima M Chang Y-F Prevalence and incidence of insulin-dependent diabetes Diabetes in America. 1995 37 46
Palosuo High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men. A nested case-control study Thromb Haemost 1997 10.1055/s-0038-1657711 78 1178
Bingley Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives Diabetes 1994 10.2337/diab.43.11.1304 43 1304
Verge Prediction of type I diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512bdc/IA-2 autoantibodies Diabetes 1996 10.2337/diab.45.7.926 45 926
Pietropaolo Combined analysis of GAD65 and ICA512 (IA-2) autoantibodies in organ and non-organ specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus J Autoimmun 1998 11 1 10.1006/jaut.1997.0170
Ziegler Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes. The 2-year analysis of the German BABYDIAB study Diabetes 1999 10.2337/diabetes.48.3.460 48 460
Wiest-Ladenburger Combined analysis and single-step detection of GAD65 and IA2 autoantibodies can replace the histochemical islet cell antibody test Diabetes 1997 10.2337/diab.46.4.565 46 565
Kulmala Prediction of insulin-dependint diabetes mellitus in siblings of children with diabetes J Clin Invest 1998 10.1172/JCI119879 101 327
W orld H ealth O rganization . World Health Organization 1980
Zimmet Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency Diabet Med 1994 10.1111/j.1464-5491.1994.tb00275.x 11 299
Rewers Diabetes in America. 1995 179
Fried The cardiovascular health study: design and rationale Ann Epidemiol 1991 10.1016/1047-2797(91)90005-W 1 263
Pietropaolo Evidence of islet cell autoimmunity in elderly patients with Type 2 diabetes mellitus Diabetes 2000 10.2337/diabetes.49.1.32 49 32
Dupré Clinical trials of Cyclosporin in IDDM Diabetes Care 1988 11 37
Bougneres Factors associated with early remission of Type I diabetes in children treated with cyclosporine N Engl J Med 1988 10.1056/NEJM198803173181103 318 663
Mahan Prediction, Prevention and Genetic Counseling. 1996 257
Lipton Cyclosporin therapy for prevention and cure of IDDM. Epidemiological perspective of benefits and risks Diabetes Care 1990 10.2337/diacare.13.7.776 13 776
Pietropaolo Current Therapy in Allergy, Immunology, and Rheumatology. 1992 365
Drash Is it the time to draw the curtain on immune intervention trials in newly diagnosed patients with IDDM? Diabetes Care 1995 10.2337/diacare.18.11.1499 18 1499
Rakotoambinina Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients Diabetes Care 1995 10.2337/diacare.18.11.1487 18 1487
Silverstein Immunosuppression with azathioprine and prednisone in recent- onset insulin-dependent diabetes mellitus N Engl J Med 1988 10.1056/NEJM198809083191002 319 599
Harrison Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine Diabetes 1985 10.2337/diab.34.12.1306 34 1306
Pozzilli The potential role of nicotinamide in the secondary prevention of IDDM Diabetes Nutr Metab 1993 9 219
Elliott A population based strategy to prevent insulin-dependent diabetes using nicotinamide J Pediatr Endocrinol Metab 1996 10.1515/JPEM.1996.9.5.501 9 501
Lampeter The Deutsche Nicotinamide Intervention Study: An attempt to prevent Type 1 diabetes. DENIS Group Diabetes 1998 10.2337/diabetes.47.6.980 47 980
DPT- The Diabetes Prevention Trial-type 1diabetes (DPT-1): implementation of screening and staging of relatives Transplant Proc 1995 27 337
Levy-Marchal Multiple beta cells antibodies are not associated with high risk HLA genotypes in schoolchildren from the general population Diabetes 1997 46 Suppl.1 198A
Pietropaolo Are GAD65 and IA-2 autoantibodies sufficient to predict Type 1 diabetes? Diabetes 1999 48 Suppl.1 A45
Cornell Absence of islet autoantibodies at diabetes onset does not rule out Type 1A diabetes Diabetes 2000 49 Suppl.1 A68
Roep T-cell responses to autoantigens in IDDM. The search for the holy grail Diabetes 1996 10.2337/diab.45.9.1147 45 1147
Brooks-Worrell Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients Diabetes 1999 10.2337/diabetes.48.5.983 48 983
Dosch Persistent T cell anergy in human type 1 diabetes J Immunol 1999 10.4049/jimmunol.163.12.6933 163 6933
Sabbah Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset Type 1 diabetes Diabetes Care 2000 10.2337/diacare.23.9.1326 23 1326
The Diabetes Control and Complication Trial Research Group. Effect of intensive therapy on residual β-cell function in patients with Type 1 diabetes in the Diabetes Control and Complication Trial. A randomized, controlled trial Ann Int Med 1998 10.7326/0003-4819-128-7-199804010-00001 128 517
Greenbaum Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical Type 1 diabetes. Follow-up of the Seattle family study Diabetes 1999 10.2337/diabetes.48.1.170 48 170
Jackson Dual parameter linear model for prediction of onset of type I diabetes in islet cell antibody positive relatives Clin Res 1988 36 585A
McCulloch The appropriate use of B-cell function testing in the preclinical period of type I diabetes Diabetic Med 1991 10.1111/j.1464-5491.1991.tb02116.x 8 800
McCulloch Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. The ICARUS Group. Islet Cell Antibody Register User's Study Diabetes Care 1993 10.2337/diacare.16.6.911 16 911
Eisenbarth Dual-parameter model for prediction of type I diabetes mellitus Proc Ass Am Phys 1998 110 126
Shah A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus N Engl J Med 1989 10.1056/NEJM198903023200902 320 550
Wahren Does C-peptide has a physiological role? Diabetologia 1994 10.1007/BF00400832 37 Suppl.2 S99
Steiner Proinsulin C-peptide-biological activity? Science 1997 277 531 10.1126/science.277.5325.531
Ohtomo Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity in synergism with neuropeptide Y Diabetologia 1998 41 287 10.1007/s001250050905
Gunaratnam Precipitation of IDDM by the ICA69 T cell epitope peptide, Tep69 Diabetes 1998 47 Suppl.1 A34
Simone Immunologic ‘vaccination’ for the prevention of autoimmune diabetes (Type 1A) Diabetes Care 1999 22 B7
Chatenaud CD3 antibody-induced dominant self tolerance on overtly diabetic NOD mice J Immunol 1997 10.4049/jimmunol.158.6.2947 158 2947
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.